Evidence map›Paper›PMID 39682743›Full record

Observational studyCells2024

Differential Infiltration of Key Immune T-Cell Populations Across Malignancies Varying by Immunogenic Potential and the Likelihood of Response to Immunotherapy.

Islam Eljilany, Sam Coleman, Aik Choon Tan, Martin D McCarter, John Carpten, Howard Colman, Abdul Rafeh Naqash, Igor Puzanov, Susanne M Arnold, Michelle L Churchman and 12 more

Abstract readMulticenter StudyObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Islam EljilanyDepartments of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.ORCID 0000-0001-6387-5419
Sam ColemanHuntsman Cancer Institute, Salt Lake City, UT 84132, USA.
Aik Choon TanHuntsman Cancer Institute, Salt Lake City, UT 84132, USA.ORCID 0000-0003-2955-8369
Martin D McCarterUniversity of Colorado Cancer Center, Aurora, CO 80045, USA.ORCID 0000-0001-8174-1713
John CarptenNorris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA.
Howard ColmanHuntsman Cancer Institute, Salt Lake City, UT 84132, USA.ORCID 0000-0002-4027-7317
Abdul Rafeh NaqashOklahoma University Health Stephenson Cancer Center, Oklahoma City, OK 73104, USA.
Igor PuzanovDepartment of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.ORCID 0000-0002-9803-3497
Susanne M ArnoldUniversity of Kentucky Markey Cancer Center, Lexington, KY 40536, USA.ORCID 0000-0001-6542-9551
Michelle L ChurchmanAster Insights, Hudson, FL 34667, USA.
Daniel SpakowiczOhio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.ORCID 0000-0003-2314-6435
Bodour SalhiaNorris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA.
Julian MarinSimon Comprehensive Cancer Center, Indiana University, Indianapolis, IN 46202, USA.ORCID 0000-0001-7067-173X
Shridar GanesanRutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA.
Aakrosh RatanDepartment of Genome Sciences, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.ORCID 0000-0002-0782-3056
Craig ShriverMurtha Cancer Center, Walter Reed National Military Medical Center, Falls Church, VA 22042-5101, USA.ORCID 0000-0001-8993-5811
Patrick HwuDepartments of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
William S DaltonAster Insights, Hudson, FL 34667, USA.
George J WeinerDepartment of Internal Medicine, Carver College of Medicine, University of Iowa Health Care, Iowa City, IA 52242, USA.ORCID 0000-0003-3427-0562
Jose R Conejo-GarciaDepartment of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.ORCID 0000-0001-6431-4074
Paulo RodriguezDepartment of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Ahmad A TarhiniDepartments of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI Jennifer F Rogers · 2013 to 2026
$38.3M
Project 4P01CA250984 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI RODRIGUEZ, PAULO CESAR · 2021 to 2025
$10.1M
NCI NIH HHS P01 CA250984NCI NIH HHS P30 CA177558ORIEN FOUNDATION NOVA and Community Foundation of Tampa Bay 69-21295-01-01
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ImmunotherapyLymphocytes, Tumor-InfiltratingNeoplasmsTumor MicroenvironmentFemaleHumansMaleMiddle AgedT-Lymphocytesbladder cancerimmune cell infiltrationimmune responsemelanomaovarian cancerpancreatic cancerRNA expressionT-cell

Identifiers

PMID39682743
PMCPMC11640164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.